Calepusan, Samuel S.
HRN: 29-23-01 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CO-AMOXICLAV 625MG (TAB)
06/28/2026
04/07/2026
PO
625
Q8
TBI
Checking Initial Appropriateness